We are a biotechnology company dedicated to developing next-generation therapeutics to improve the lives of patients with severe and life-altering brain diseases. Bright Minds’ broad portfolio of new chemical entities (NCEs) are positioned to treat a variety of pain indications, seizures, and neuropsychiatric disorders.
The team working at Bright Minds is dedicated to developing extremely innovative therapies for addressing the most relevant and unmet medical requirements. In this manner, it has led to the paradigm transformation in the whole of the mental health space.
/image%2F6304363%2F20210225%2Fob_c47acc_clock-5701307-1280.jpg)
/image%2F6304363%2F20210222%2Fob_7ae4f0_man-4075279-1280.jpg)
/image%2F6304363%2F20210218%2Fob_315e03_drugdeveloper-brightminds.jpg)
/image%2F6304363%2F20210217%2Fob_99722f_epilepsy.jpg)